Literature DB >> 19605689

Regulation of transgenes in three-dimensional cultures of primary mouse mammary cells demonstrates oncogene dependence and identifies cells that survive deinduction.

Martin Jechlinger1, Katrina Podsypanina, Harold Varmus.   

Abstract

The advent of targeted therapies for cancer has provoked interest in experimental models for the systematic study of oncogene dependence. To that end, we developed a three-dimensional (3D) culture system to analyze the responses of primary mouse mammary epithelial cells to the induction and deinduction of oncogenes. Mammary cells derived from normal virgin mice, or from tritransgenic mice (TetO-MYC;TetO-Kras(G12D);MMTV-rtTA) in which MYC and mutant Kras can be regulated by doxycycline, develop from single cells into polarized acini. Lumen formation occurs without apparent apoptosis, and the hollow spheres of cells enlarge by division, with metaphase plates oriented perpendicularly to the apical surface. When MYC and Kras(G12D) are induced, the acini enlarge and form solid, depolarized spheres. Upon deinduction of MYC and Kras(G12D) the solid structures regress, leaving a repolarized monolayer of viable cells. These cells display a phenotype consistent with progenitors of mammary epithelium: They exclude Hoechst dye 33342, and reform acini in 3D cultures and repopulate mammary fat pads more efficiently than cells harvested from uninduced acini. Moreover, cells in the surviving spheres retain the ability to respond to reinduction and thus may represent the type of cells that give rise to recurrent tumors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19605689      PMCID: PMC2714708          DOI: 10.1101/gad.1801809

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  49 in total

1.  Initial formation of zebrafish brain ventricles occurs independently of circulation and requires the nagie oko and snakehead/atp1a1a.1 gene products.

Authors:  Laura Anne Lowery; Hazel Sive
Journal:  Development       Date:  2005-03-23       Impact factor: 6.868

2.  Bim regulation of lumen formation in cultured mammary epithelial acini is targeted by oncogenes.

Authors:  Mauricio J Reginato; Kenna R Mills; Esther B E Becker; Danielle K Lynch; Azad Bonni; Senthil K Muthuswamy; Joan S Brugge
Journal:  Mol Cell Biol       Date:  2005-06       Impact factor: 4.272

3.  Essential role for oncogenic Ras in tumour maintenance.

Authors:  L Chin; A Tam; J Pomerantz; M Wong; J Holash; N Bardeesy; Q Shen; R O'Hagan; J Pantginis; H Zhou; J W Horner; C Cordon-Cardo; G D Yancopoulos; R A DePinho
Journal:  Nature       Date:  1999-07-29       Impact factor: 49.962

4.  Requirement for focal adhesion kinase in the early phase of mammary adenocarcinoma lung metastasis formation.

Authors:  Maroesja J van Nimwegen; Saertje Verkoeijen; Liesbeth van Buren; Danny Burg; Bob van de Water
Journal:  Cancer Res       Date:  2005-06-01       Impact factor: 12.701

5.  Reversible tumorigenesis by MYC in hematopoietic lineages.

Authors:  D W Felsher; J M Bishop
Journal:  Mol Cell       Date:  1999-08       Impact factor: 17.970

6.  Activation of an inducible c-FosER fusion protein causes loss of epithelial polarity and triggers epithelial-fibroblastoid cell conversion.

Authors:  E Reichmann; H Schwarz; E M Deiner; I Leitner; M Eilers; J Berger; M Busslinger; H Beug
Journal:  Cell       Date:  1992-12-24       Impact factor: 41.582

7.  Experimental mammary epithelial morphogenesis in an in vivo model: evidence for distinct cellular progenitors of the ductal and lobular phenotype.

Authors:  G H Smith
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

Review 8.  The mammary gland "side population": a putative stem/progenitor cell marker?

Authors:  Matthew J Smalley; Robert B Clarke
Journal:  J Mammary Gland Biol Neoplasia       Date:  2005-01       Impact factor: 2.673

9.  Cellular growth and survival are mediated by beta 1 integrins in normal human breast epithelium but not in breast carcinoma.

Authors:  A R Howlett; N Bailey; C Damsky; O W Petersen; M J Bissell
Journal:  J Cell Sci       Date:  1995-05       Impact factor: 5.285

10.  An atypical PKC directly associates and colocalizes at the epithelial tight junction with ASIP, a mammalian homologue of Caenorhabditis elegans polarity protein PAR-3.

Authors:  Y Izumi; T Hirose; Y Tamai; S Hirai; Y Nagashima; T Fujimoto; Y Tabuse; K J Kemphues; S Ohno
Journal:  J Cell Biol       Date:  1998-10-05       Impact factor: 10.539

View more
  35 in total

1.  Modeling invasive breast cancer: growth factors propel progression of HER2-positive premalignant lesions.

Authors:  C-R Pradeep; A Zeisel; W J Köstler; M Lauriola; J Jacob-Hirsch; B Haibe-Kains; N Amariglio; N Ben-Chetrit; A Emde; I Solomonov; G Neufeld; M Piccart; I Sagi; C Sotiriou; G Rechavi; E Domany; C Desmedt; Y Yarden
Journal:  Oncogene       Date:  2011-12-05       Impact factor: 9.867

Review 2.  Cell polarity in motion: redefining mammary tissue organization through EMT and cell polarity transitions.

Authors:  Nathan J Godde; Ryan C Galea; Imogen A Elsum; Patrick O Humbert
Journal:  J Mammary Gland Biol Neoplasia       Date:  2010-05-12       Impact factor: 2.673

3.  The Deleted in Liver Cancer 1 (Dlc1) tumor suppressor is haploinsufficient for mammary gland development and epithelial cell polarity.

Authors:  Pratima Basak; Rachelle Dillon; Heather Leslie; Afshin Raouf; Michael R A Mowat
Journal:  BMC Cancer       Date:  2015-09-09       Impact factor: 4.430

4.  Dual function of Yap in the regulation of lens progenitor cells and cellular polarity.

Authors:  Ji Yun Song; Raehee Park; Jin Young Kim; Lucinda Hughes; Li Lu; Seonhee Kim; Randy L Johnson; Seo-Hee Cho
Journal:  Dev Biol       Date:  2013-12-31       Impact factor: 3.582

5.  Tumorigenesis: Replicating recurrence.

Authors:  Nicola McCarthy
Journal:  Nat Rev Cancer       Date:  2009-09       Impact factor: 60.716

6.  KRAS and YAP1 converge to regulate EMT and tumor survival.

Authors:  Diane D Shao; Wen Xue; Elsa B Krall; Arjun Bhutkar; Federica Piccioni; Xiaoxing Wang; Anna C Schinzel; Sabina Sood; Joseph Rosenbluh; Jong W Kim; Yaara Zwang; Thomas M Roberts; David E Root; Tyler Jacks; William C Hahn
Journal:  Cell       Date:  2014-06-19       Impact factor: 41.582

7.  Metabolic shifts in residual breast cancer drive tumor recurrence.

Authors:  Kristina M Havas; Vladislava Milchevskaya; Ksenija Radic; Ashna Alladin; Eleni Kafkia; Marta Garcia; Jens Stolte; Bernd Klaus; Nicole Rotmensz; Toby J Gibson; Barbara Burwinkel; Andreas Schneeweiss; Giancarlo Pruneri; Kiran R Patil; Rocio Sotillo; Martin Jechlinger
Journal:  J Clin Invest       Date:  2017-05-15       Impact factor: 14.808

8.  A P53-Independent DNA Damage Response Suppresses Oncogenic Proliferation and Genome Instability.

Authors:  Katerina D Fagan-Solis; Dennis A Simpson; Rashmi J Kumar; Luciano G Martelotto; Lisle E Mose; Naim U Rashid; Alice Y Ho; Simon N Powell; Y Hannah Wen; Joel S Parker; Jorge S Reis-Filho; John H J Petrini; Gaorav P Gupta
Journal:  Cell Rep       Date:  2020-02-04       Impact factor: 9.423

9.  A Combination RNAi-Chemotherapy Layer-by-Layer Nanoparticle for Systemic Targeting of KRAS/P53 with Cisplatin to Treat Non-Small Cell Lung Cancer.

Authors:  Li Gu; Zhou J Deng; Sweta Roy; Paula T Hammond
Journal:  Clin Cancer Res       Date:  2017-09-14       Impact factor: 12.531

10.  Chromosome Segregation Fidelity in Epithelia Requires Tissue Architecture.

Authors:  Kristin A Knouse; Kristina E Lopez; Marc Bachofner; Angelika Amon
Journal:  Cell       Date:  2018-08-23       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.